ArticleeLife2020
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells.
Yvette Robbins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it
ArticleeLife2020
Yvette Robbins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.